What we're reading, August 8, 2016: a new Medicare law would require hospitals to notify patients about loopholes in nursing home coverage; e-cigarette makers flooded the market ahead of new regulation implementation; and California bill on nurse-midwife independents causes controversy.
A new Medicare law requires hospitals to notify patients about huge out-of-pocket costs that they might incur if they stay at a hospital without formally being admitted. According to The New York Times, patients will receive notices if they receive observation services as an outpatient for more than 24 hours because Medicare would not pay for subsequent nursing home care. Hospitals will likely have to issue 1.4 million notices a year under the new law.
With new federal regulations taking effect, makers of vaping devices flooded the market with new products in the United States. E-cigarette devices on the market before the regulations took effect can be sold for up to 3 years while awaiting regulatory review, reported Reuters. Products like e-cigarettes, cigars, pope tobacco, and hookah tobacco will need to be submitted for government approval under the new rules. To beat the regulatory deadline, many companies shipped limited shipments and product prototypes.
A new bill in California that would all certified nurse-midwives to practice independently has caused controversy. The current law requires certified nurse-midwives to practice under the supervision of medical doctors, and doctors opposing the proposed bill argue that hospitals should not be able to employ midwives directly, according to California Healthline. There are only 6 states that require full supervision. In those states that allow nurse-midwives to practice independently, there is more access to care.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More